Hikal has started limited operations on April 05, 2020, at all its manufacturing factories in Taloja (Maharashtra), Mahad (Maharashtra), Panoli (Gujarat), Bengaluru (Karnataka) and the R&D facility located in Pune (Maharashtra). The company has received permission from the government authorities to restart its operations since it is provider of the essential services (Pharmaceutical and Continuous Industries) which are exempted from the lockdown.
The company expects operations to ramp up over the next several days and is ensuring compliance with the directives issued by the Central Government, State Governments and local government and is maintaining social distancing and taking the required precautions for all its staff. Due to the continued restriction in the movement of goods and people by the government, the company will not be able to operate at its optimal capacity. The company remains committed to the health and safety of its employees, their families and communities in which they operate.
Hikal is engaged in R&D, manufacturing and marketing of fine chemicals for the Pharmaceutical and Agrochemical industries
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1620.50 |
Dr. Reddys Lab | 6171.85 |
Cipla | 1494.65 |
Zydus Lifesciences | 1013.75 |
Lupin | 1617.85 |
View more.. |